Fear of recurrence: Results of a randomized trial of relapse detection in schizophrenia
- 8 July 2014
- journal article
- research article
- Published by Wiley in British Journal of Clinical Psychology
- Vol. 54 (1) , 49-62
Abstract
Objective: We aimed to develop and establish the reliability and validity of a measure of Fear of Recurrence, measuring cognitive appraisals of relapse rather than standard early signs of relapse. We also aimed to establish the sensitivity and specificity to relapse. Method: Participants diagnosed with schizophrenia or a related disorder were randomized to one of two early signs monitoring conditions, using either the Early Signs Scale or the Fear of Recurrence Scale (FoRSe). Participants were followed up for 6‐months or until relapse. Results: A total of 169 participants were randomized to Standard ( n = 86) or Fo RS e ( n = 83) monitoring. We found good evidence supporting reliability and validity of the Fo RS e. In addition, a cut‐off point of ≥5 was associated with an optimal sensitivity in both Standard ( n = 26:79%, 95% CI = 62–89) and Fo RS e ( n = 18:72%, 95% CI = 52–86) monitoring. However, this degree of sensitivity was associated with a lower specificity in Standard ( n = 30:35%, 96% CI = 23–50) and Fo RS e ( n = 25:46%, 95% CI = 32–60). Finally, Fear of Relapse was a significant predictor of time to relapse [Exp(β) = 1.20, 95% CI = 1.01–1.42, p < .05]. Conclusion: The study provides evidence that Fear of Recurrence may be an important clinical construct linked to increased risk of relapse and poorer emotional recovery in people diagnosed with schizophrenia. Practitioner points: Monitoring Fear of Recurrence is as sensitive to relapse detection as monitoring early signs alone. Greater Fear of Relapse was associated with shorter duration to actual relapse. Fear of recurrence may be an important clinical feature linked to poorer emotional recovery and increased risk of relapse. Fear of Recurrence may be an important focus of psychological therapy to promote emotional recovery and prevention of relapse.Keywords
Funding Information
- Chief Scientist Office (CZG/4/8)
This publication has 40 references indexed in Scilit:
- Integrating mobile-phone based assessment for psychosis into people’s everyday lives and clinical care: a qualitative studyBMC Psychiatry, 2013
- A Randomized Controlled Trial of Relapse Prevention Therapy for First-Episode Psychosis Patients: Outcome at 30-Month Follow-UpSchizophrenia Bulletin, 2011
- A Compassion Focused Model of Recovery after PsychosisInternational Journal of Cognitive Therapy, 2010
- A systematic review of relapse measurement in randomized controlled trials of relapse prevention in first-episode psychosisSchizophrenia Research, 2010
- Basic symptoms in early psychotic and depressive disordersThe British Journal of Psychiatry, 2007
- A family‐based model to predict fear of recurrence for cancer survivors and their caregiversPsycho-Oncology, 2006
- Early warning signs of relapse following a first episode of psychosisSchizophrenia Research, 2005
- Early intervention for relapse in schizophrenia: results of a 12-month randomized controlled trial of cognitive behavioural therapyPsychological Medicine, 2003
- The development and implementation of an individualised early signs monitoring system in the prediction of relapse in schizophreniaJournal of Mental Health, 2002
- Early signs of psychotic relapse in schizophreniaThe British Journal of Psychiatry, 1998